SYNLOGIC, INC. Retained Earnings
SYNLOGIC, INC. (SYBX) had Retained Earnings of -$442.52 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-11
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$442.52M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$441.98M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$442.66M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$444.16M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$442.52M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | -$441.98M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$442.66M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | -$444.16M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$441.86M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$441.33M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$441.65M 10-K · filed 2026-03-12 | |
| 2024-09-30 | -$440.94M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$440.82M 10-Q · filed 2024-11-12 | -$443.85M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$443.90M 10-Q · filed 2024-11-12 | -$445.87M 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$418.29M 10-K · filed 2025-03-06 | -$414.30M 10-K · filed 2024-03-19 |
| 2023-09-30 | -$399.77M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$387.69M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$372.64M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$357.02M 10-K · filed 2024-03-19 | |
| 2022-09-30 | -$340.32M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$322.41M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$306.57M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$290.87M 10-K · filed 2023-03-29 | |
| 2021-09-30 | -$275.78M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | -$259.77M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$245.28M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$230.31M 10-K · filed 2022-03-17 | |
| 2020-09-30 | -$215.72M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | -$202.50M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | -$186.97M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | -$171.14M 10-K · filed 2021-03-25 | |
| 2019-09-30 | -$158.34M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$145.06M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$132.71M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$119.77M 10-K · filed 2020-03-12 | |
| 2018-09-30 | -$107.83M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | -$97.09M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$82.50M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$71.65M 10-K · filed 2019-03-12 | |
| 2017-09-30 | -$59.96M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | -$17.00K 10-Q · filed 2017-08-04 | |
| 2017-03-31 | -$17.00K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$31.25M 10-K · filed 2018-03-20 | -$102.79M 10-K · filed 2017-03-15 |
| 2016-09-30 | -$94.10M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | -$88.73M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$83.09M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | -$76.52M 10-K · filed 2017-03-15 | |
| 2015-09-30 | -$67.73M 10-Q · filed 2015-11-13 | |
| 2014-12-31 | -$47.95M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |